craniofacial
• reduced in size or absent in E17.5 embryos
|
• in E17.5 embryos
|
• in E17.5 embryos
|
• excessively fused or absent in E17.5 embryos
|
• reduced length in E17.5 embryos
|
round head
(
J:306254
)
• in E17.5 embryos
|
endocrine/exocrine glands
• absent oxytocin and vasopressin expressing cells in paraventricular nucleus (PVN) in E15.5 embryos
|
• absent oxytocin, tyrosine hydroxylase (TH1) and vasopressin expressing cells in paraventricular nucleus (PVN) in E15.5 embryos
|
• mislocated in E17.5 embryos, intercepting the basisphenoid bone
|
• shifted ventrally in E11.5 embryos
• severely malformed in E13.5 embryos
|
• less separation of infundibulum from neuroectodermal tissue in E13.5 embryos
• undergoing apoptosis in E17.5 embryos
|
• infundibulum shifted ventrally in E11.5 embryos, remaining ectopic in E15.5 embryos
|
growth/size/body
• reduced length in E17.5 embryos
|
round head
(
J:306254
)
• in E17.5 embryos
|
mortality/aging
• expected Mendelian ratios at stage E17.5
• premature death by age P4
|
nervous system
• mislocated in E17.5 embryos, intercepting the basisphenoid bone
|
• shifted ventrally in E11.5 embryos
• severely malformed in E13.5 embryos
|
• less separation of infundibulum from neuroectodermal tissue in E13.5 embryos
• undergoing apoptosis in E17.5 embryos
|
• infundibulum shifted ventrally in E11.5 embryos, remaining ectopic in E15.5 embryos
|
• midline hypothalamic brain tissue absent in E17.5 embryos
|
• absent oxytocin and vasopressin expressing cells in paraventricular nucleus (PVN) in E15.5 embryos
|
• absent oxytocin, tyrosine hydroxylase (TH1) and vasopressin expressing cells in paraventricular nucleus (PVN) in E15.5 embryos
|
respiratory system
• reduced length in E17.5 embryos
|
skeleton
• reduced in size or absent in E17.5 embryos
|
• in E17.5 embryos
|
• in E17.5 embryos
|
• excessively fused or absent in E17.5 embryos
|